Pharma
When was the last time any of us took a medical book to a hospital? Loads of medical records from previous consultations and every bill. Dr Shivdev Rao, felt that rather than saving lives of patients as a cardiologist he was wasting much more time in writing his notes. To help more patients and doctors he introduced Abridge, a healthtech firm located in downtown Pittsburgh which provides a solution in the form of an app that captures and summarises patient-doctor discussions.
Founded in 2018, Shiv Rao, a cardiologist with a flair for innovation, pitched a startup idea to Andy Weissman, a general partner at Union Square Ventures (USV), describing it as a blend of SoundCloud and RapGenius for medicine. While the comparison to music and lyrics platforms initially amused Weissman, Rao's vision quickly captured his attention. Rao highlighted the burden of administrative tasks on doctors, who spend hours outside of regular work meticulously typing notes, leading to burnout and driving some out of the profession. Rao believed that AI could alleviate this burden, a concept that resonated with Weissman despite being proposed years before generative AI gained mainstream traction. Rao's credibility as a physician at the University of Pittsburgh Medical Center, his role as a corporate venture capitalist in health tech, and his team's expertise from Carnegie Mellon, a leader in AI research, ultimately convinced Weissman and his USV partners to take a chance on what once seemed like a wacky idea.
The company's rapid growth and adoption by major health systems like Yale, Emory, and University of Chicago showcase its value. Described as "life-changing" and "magical" by users, Abridge is transforming the healthcare experience for both doctors and patients. With its recent $150 million Series C funding and a valuation of $850 million, Abridge is positioned at the forefront of AI-powered healthcare solutions, potentially becoming the "Duolingo of healthcare" in terms of widespread impact and adoption.
